Home >> Tag Archives: Owlstone Medical—

Tag Archives: Owlstone Medical—

Owlstone’s asthma breath test CE marked

Oct. 5, 2016—Owlstone Medical has received CE mark approval for a pediatric version of the company’s disease breathalyzer, ReCIVA. The marking extends the scope of breath testing in early-stage diagnostics and therapy response to include children and, in particular, the difficult to manage group of child asthma patients. The adult and pediatric versions of the breathalyzer are being used in ...

Read More »